220 related articles for article (PubMed ID: 19494144)
1. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.
Drew GM; Lau BK; Vaughan CW
J Neurosci; 2009 Jun; 29(22):7220-9. PubMed ID: 19494144
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
Mitchell VA; Kawahara H; Vaughan CW
J Physiol; 2009 Jun; 587(Pt 11):2511-20. PubMed ID: 19359367
[TBL] [Abstract][Full Text] [Related]
3. Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling.
Drew GM; Mitchell VA; Vaughan CW
J Neurosci; 2008 Jan; 28(4):808-15. PubMed ID: 18216189
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.
Mitchell VA; Jeong HJ; Drew GM; Vaughan CW
Neuropsychopharmacology; 2011 Aug; 36(9):1801-10. PubMed ID: 21525858
[TBL] [Abstract][Full Text] [Related]
5. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.
Liao HT; Lee HJ; Ho YC; Chiou LC
Br J Pharmacol; 2011 May; 163(2):330-45. PubMed ID: 21232043
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.
Aubrey KR; Drew GM; Jeong HJ; Lau BK; Vaughan CW
J Physiol; 2017 Jan; 595(1):165-178. PubMed ID: 27461371
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray.
Lau BK; Vaughan CW
Mol Pharmacol; 2008 Nov; 74(5):1392-8. PubMed ID: 18678620
[TBL] [Abstract][Full Text] [Related]
8. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
9. Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway.
Lau BK; Winters BL; Vaughan CW
Br J Pharmacol; 2020 May; 177(10):2320-2332. PubMed ID: 31971607
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic modulation of primary afferent glutamatergic transmission in rat medullary dorsal horn neurons.
Jeong SG; Choi IS; Cho JH; Jang IS
Neuropharmacology; 2013 Dec; 75():295-303. PubMed ID: 23954675
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin excites periaqueductal gray neurons projecting to the rostral ventromedial medulla.
Li AH; Hwang HM; Tan PP; Wu T; Wang HL
J Neurophysiol; 2001 Apr; 85(4):1479-88. PubMed ID: 11287471
[TBL] [Abstract][Full Text] [Related]
12. Purinergic P2X receptors presynaptically increase glutamatergic synaptic transmission in dorsolateral periaqueductal gray.
Xing J; Lu J; Li J
Brain Res; 2008 May; 1208():46-55. PubMed ID: 18395189
[TBL] [Abstract][Full Text] [Related]
13. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
14. Activation of mu-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons.
Finnegan TF; Li DP; Chen SR; Pan HL
J Pharmacol Exp Ther; 2004 May; 309(2):476-83. PubMed ID: 14724227
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro.
Vaughan CW; Christie MJ
J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):463-72. PubMed ID: 9032693
[TBL] [Abstract][Full Text] [Related]
16. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
17. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling.
Haj-Dahmane S; Shen RY
J Neurosci; 2005 Jan; 25(4):896-905. PubMed ID: 15673670
[TBL] [Abstract][Full Text] [Related]
18. Endocannabinoid-dependent homeostatic regulation of inhibitory synapses by miniature excitatory synaptic activities.
Zhang SY; Xu M; Miao QL; Poo MM; Zhang XH
J Neurosci; 2009 Oct; 29(42):13222-31. PubMed ID: 19846710
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 (PGE2) inhibits glutamatergic synaptic transmission in dorsolateral periaqueductal gray (dl-PAG).
Lu J; Xing J; Li J
Brain Res; 2007 Aug; 1162():38-47. PubMed ID: 17612511
[TBL] [Abstract][Full Text] [Related]
20. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats.
Escobar W; Ramirez K; Avila C; Limongi R; Vanegas H; Vazquez E
Eur J Pain; 2012 May; 16(5):676-89. PubMed ID: 22337336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
